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The generation of genetically engineered production CHO cell lines is normally the longest step in the 
race to scale-up protein manufacturing.  This labor-intensive screening includes the expansion of hundreds of 
clonal cultures to sufficient numbers for their growth and productivity to be evaluated. Unfortunately, many 
clones that perform well when screened at the batch cloning stage display reduced performance under fed-
batch conditions. Thus, screening potential clones under conditions more similar to the ultimate production 
cultures provides an opportunity for more effective clone selection. 
 
 We combined the advantages of precise measurements in microfluidic nL volume cultures with our 
ability to modify the medium during cultures where clones are retained in thousands of isolated chambers. Our 
bead assay coupled with an automated image analysis pipeline quickly and reproducibly detected as little as 106 
human IgG molecules in 4 nL chambers after 2 h of incubation.  Thus, it is possible to evaluate the production of 
a single high performance CHO cell at the very start of the microfluidic culture.  To further evaluate the 
performance of CHO-S clones under production conditions, we perfused media from untransfected parental 
CHO-S fed-batch cultures into the microfluidic device daily.  This conditioned medium perfusion technique was 
developed using an automated robotic 24-well deep well plate culture system to demonstrate that clones in 
perfused fed-batch medium matched the growth profiles and specific productivities of those in larger scale fed-
batches.  This was replicated for multiple clonal CHO-S and CHO-K1 cell lines.  Analysis of both the growth rate 
and productivity of the microfluidic cultures enabled the screening of hundreds of cultures in parallel under 
simulated fed-batch conditions. The dynamic nature of our microfluidic assay coupled with the perfusion of 
conditioned medium in nanoliter volumes enables more rapid and effective characterization of clonal CHO cell 
performance, thereby accelerating progress towards the manufacturing of valuable products. 
